Craft

TFF Pharmaceuticals

Stock Price

$2.1

2024-10-29

Market Capitalization

$8.5 M

2024-10-29

Revenue

$733.9 K

FY, 2023

TFF Pharmaceuticals Summary

Company Summary

Overview
TFF Pharmaceuticals is a biopharmaceutical company focused on developing drug products based on the Thin Film Freezing (TFF) technology platform. It develops inhalation drug products to treat chronic respiratory diseases and lung conditions. The company generates dry powder inhaler version of drugs.
Type
Public
Status
Active
Founded
2018
HQ
Austin, TX, US | view all locations
Website
https://tffpharma.com/
Cybersecurity rating
Sectors

Key People

LocationsView all

1 location detected

  • Austin, TX HQ

    United States

    2600 Vía Fortuna #360

TFF Pharmaceuticals Financials

Summary Financials

Revenue (Q3, 2024)
$193.4K
Net income (Q3, 2024)
($3.5M)
Cash (Q3, 2024)
$2.6M
EBIT (Q3, 2024)
($3.6M)
Enterprise value
$5.9M

Footer menu